Bio
Dr. Allison is the Director of Breast Pathology at Stanford and Vice Chair of Education for the Dept of Pathology. Her research interests include prognostic/predictive markers in breast cancer, standards in HER2 and ER testing, management of risk lesions, diagnostic criteria and diagnostic agreement in breast pathology and patient communication. She is on the editorial board for the 5th and 6th editions of the WHO Classification of Tumours of the Breast, is co-chair of the ASCO/CAP ER/PR Testing in Breast Cancer committee, was on the steering committee for the 2023 and 2018 ASCO/CAP HER2 Testing Guidelines Update, and serves on the NCCN Breast Cancer Treatment Guidelines committee and the CAP Cancer Committee. She is actively involved in resident/fellow training as Director of the Stanford Breast Pathology Fellowship and is the former Residency Director for the Department of Pathology. Dr. Allison is also a breast cancer survivor and the author of “Red Sunshine; A Story of Strength and Inspiration from a Doctor Who Survived Stage 3 Breast Cancer.”
